オープン アクセスを義務付けられた論文 - Roberta Carosio詳細
一般には非公開: 4 件
Epigenetic dysregulation in neuroblastoma: A tale of miRNAs and DNA methylation
F Parodi, R Carosio, M Ragusa, C Di Pietro, M Maugeri, D Barbagallo, ...
Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1859 (12 …, 2016
委任: Government of Italy
CTLA-4 gene variant-1661A> G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab
P Queirolo, B Dozin, A Morabito, B Banelli, R Carosio, V Fontana, ...
European Journal of Cancer 97, 59-61, 2018
委任: Government of Italy
Phenotypic characterization of tumor CTLA-4 expression in melanoma tissues and its possible role in clinical response to Ipilimumab
MP Pistillo, R Carosio, F Grillo, V Fontana, L Mastracci, A Morabito, ...
Clinical immunology 215, 108428, 2020
委任: Government of Italy
Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: Potential implications in the immune response and prognosis
R Carosio, V Fontana, L Mastracci, P Ferro, F Grillo, B Banelli, ...
Journal of Cancer Research and Clinical Oncology 147, 459-468, 2021
委任: Government of Italy, AIRC Foundation for Cancer Research in Italy
一般公開: 11 件
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma
B Banelli, E Carra, F Barbieri, R Würth, F Parodi, A Pattarozzi, R Carosio, ...
Cell Cycle 14 (21), 3418-3429, 2015
委任: Government of Italy
Immune checkpoints and innovative therapies in glioblastoma
M Romani, MP Pistillo, R Carosio, A Morabito, B Banelli
Frontiers in oncology 8, 464, 2018
委任: Government of Italy
Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study
MP Pistillo, V Fontana, A Morabito, B Dozin, S Laurent, R Carosio, ...
Cancer Immunology, Immunotherapy 68, 97-107, 2019
委任: Government of Italy
Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines
S Boero, A Morabito, B Banelli, B Cardinali, B Dozin, G Lunardi, P Piccioli, ...
Journal of translational medicine 13, 1-14, 2015
委任: Government of Italy
The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response
G Pagnan, D Di Paolo, R Carosio, F Pastorino, D Marimpietri, C Brignole, ...
Clinical Cancer Research 15 (4), 1199-1209, 2009
委任: US National Institutes of Health
Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study
P Queirolo, B Dozin, A Morabito, B Banelli, P Piccioli, C Fava, C Leo, ...
Frontiers in immunology 8, 386, 2017
委任: Government of Italy
IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade
MP Pistillo, R Carosio, B Banelli, A Morabito, L Mastracci, P Ferro, ...
Cellular & Molecular Immunology 17 (4), 410-411, 2020
委任: Government of Italy
Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization
L Mastracci, V Fontana, P Queirolo, R Carosio, F Grillo, A Morabito, ...
Cancer Immunology, Immunotherapy 69 (4), 653-662, 2020
委任: Government of Italy
Potential role of serum mesothelin in predicting survival of patients with malignant pleural mesothelioma
V Fontana, MP Pistillo, A Vigani, PA Canessa, G Berisso, U Giannoni, ...
Oncology letters 21 (2), 128, 2021
委任: Government of Italy
Determination of mesothelin levels in pleural effusion does not help predict survival of patients with malignant pleural mesothelioma
V Fontana, MP Pistillo, A Vigani, PA Canessa, G Berisso, U Giannoni, ...
Anticancer Research 39 (9), 5219-5223, 2019
委任: Government of Italy
Abbreviations: BOR, best overall response; CTLA-4, cytotoxic T lymphocyte antigen-4; EAP, expanded access program; IMI, Italian Melanoma Intergroup; IPI, ipilimumab; MLR …
M Bellone, E Castanon, JM Piulats, MP Pistillo, P Queirolo, B Dozin, ...
Frontiers in Immunology 8 (386), 1, 2017
委任: Government of Italy
公開と助成金に関する情報は、コンピュータ プログラムによって自動的に決定されます